ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,565,055 | -31.0% | 142,900 | -21.9% | 0.02% | -37.5% |
| Q2 2023 | $3,717,216 | -30.6% | 183,024 | -37.7% | 0.03% | -37.3% |
| Q1 2023 | $5,359,093 | +67.9% | 293,810 | +90.4% | 0.05% | +88.9% |
| Q4 2022 | $3,191,731 | -6.6% | 154,339 | +18.2% | 0.03% | -6.9% |
| Q3 2022 | $3,417,000 | -18.6% | 130,628 | -21.1% | 0.03% | -29.3% |
| Q2 2022 | $4,196,000 | +316.3% | 165,588 | +565.0% | 0.04% | +355.6% |
| Q4 2021 | $1,008,000 | +18.4% | 24,900 | +2.0% | 0.01% | 0.0% |
| Q3 2021 | $851,000 | -40.2% | 24,400 | -51.9% | 0.01% | -47.1% |
| Q1 2021 | $1,424,000 | +250.7% | 50,701 | +224.5% | 0.02% | +240.0% |
| Q4 2020 | $406,000 | – | 15,625 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |